Longitudinal Electrophysiological Recovery Following Immunotherapy in Sjögren’s Syndrome-Associated Peripheral Neuropathy: A Case Report

Peripheral neuropathy is one of the most heterogeneous extraglandular manifestations of Sjögren's disease (SjD), and optimal treatment strategies remain uncertain. We report a patient with SjD-associated peripheral neuropathy who showed marked clinical and electrophysiological improvement following immunotherapy. A 68-year-old woman presented with progressive distal paresthesia, lower-limb weakness, gait instability, and sensory impairment. Nerve conduction studies demonstrated markedly reduced compound muscle action potential amplitudes in the left tibial nerve, conduction block-like abnormalities in the right tibial and left peroneal nerves, and an absent left sural sensory response. Anti-SSA/Ro antibody positivity and an abnormal Schirmer test met the 2016 ACR/EULAR classification criteria for SjD. Treatment was initiated with intravenous immunoglobulin, followed by two courses of intravenous methylprednisolone because of persistent distal weakness and pain. Muscle strength, sensory symptoms, and gait progressively improved after treatment. Serial nerve conduction studies performed at 1, 6, and 10 months demonstrated sustained electrophysiological recovery, including increased compound muscle action potential amplitudes, improvement in previously observed conduction abnormalities, and reappearance of previously absent sensory nerve action potentials. Although severe axonal loss limited definitive electrophysiological classification, the favorable clinical response and serial improvement in nerve conduction findings suggest that reversible nerve dysfunction may have contributed to the neuropathy. This case highlights that SjD should be considered in patients with otherwise unexplained peripheral neuropathy, even in the absence of prominent sicca symptoms. Serial nerve conduction studies may provide an objective means of monitoring treatment response in SjD-associated peripheral neuropathy.

Authors

Institutions

Publication Details

Journal
Modern Rheumatology Case Reports
Published
2026-11-20
DOI
https://doi.org/10.1093/mrcr/rxag110
Primary Topic
Peripheral Neuropathies and Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Longitudinal Electrophysiological Recovery Following Immunotherapy in Sjögren’s Syndrome-Associated Peripheral Neuropathy: A Case Report

Noriyuki Miyaue, Chikako Ochi, Masahiro Nagai, Yuko Ito et al.
Modern Rheumatology Case Reports
Peripheral Neuropathies and Disorders
article

Longitudinal Electrophysiological Recovery Following Immunotherapy in Sjögren’s Syndrome-Associated Peripheral Neuropathy: A Case Report

Noriyuki Miyaue, Chikako Ochi, Masahiro Nagai, Yuko Ito, Rina Ando
article en

Abstract

Peripheral neuropathy is one of the most heterogeneous extraglandular manifestations of Sjögren's disease (SjD), and optimal treatment strategies remain uncertain. We report a patient with SjD-associated peripheral neuropathy who showed marked clinical and electrophysiological improvement following immunotherapy. A 68-year-old woman presented with progressive distal paresthesia, lower-limb weakness, gait instability, and sensory impairment. Nerve conduction studies demonstrated markedly reduced compound muscle action potential amplitudes in the left tibial nerve, conduction block-like abnormalities in the right tibial and left peroneal nerves, and an absent left sural sensory response. Anti-SSA/Ro antibody positivity and an abnormal Schirmer test met the 2016 ACR/EULAR classification criteria for SjD. Treatment was initiated with intravenous immunoglobulin, followed by two courses of intravenous methylprednisolone because of persistent distal weakness and pain. Muscle strength, sensory symptoms, and gait progressively improved after treatment. Serial nerve conduction studies performed at 1, 6, and 10 months demonstrated sustained electrophysiological recovery, including increased compound muscle action potential amplitudes, improvement in previously observed conduction abnormalities, and reappearance of previously absent sensory nerve action potentials. Although severe axonal loss limited definitive electrophysiological classification, the favorable clinical response and serial improvement in nerve conduction findings suggest that reversible nerve dysfunction may have contributed to the neuropathy. This case highlights that SjD should be considered in patients with otherwise unexplained peripheral neuropathy, even in the absence of prominent sicca symptoms. Serial nerve conduction studies may provide an objective means of monitoring treatment response in SjD-associated peripheral neuropathy.

Modern Rheumatology Case Reports
Ehime University (JP)
Good health and well-being
Peripheral Neuropathies and Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon